These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 749196)

  • 41. Correction of altered noradrenaline reactivity in essential hypertension by indapamide.
    Grimm M; Weidmann P; Meier A; Keusch G; Ziegler W; Glück Z; Beretta-Piccoli C
    Curr Med Res Opin; 1983; 8 Suppl 3():38-46. PubMed ID: 6352184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Sympathetic activity in patients with normal blood pressure and with essential hypertension].
    Brecht HM; Schoeppe W
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():280-3. PubMed ID: 611963
    [No Abstract]   [Full Text] [Related]  

  • 43. Plasma adrenaline and noradrenaline in essential hypertension and after long-term treatment with beta-adrenoreceptor-blocking agents.
    Franco-Morselli R; Baudouin-Legros M; Meyer P
    Clin Sci Mol Med Suppl; 1978 Dec; 4():97s-100s. PubMed ID: 32010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The role of catecholamines in hypertensive mechanisms of essential hypertension].
    Iimura O; Kikuchi K; Yamaji I; Suzuki S; Shimazaki M; Kudo C; Mukai H
    Nihon Rinsho; 1989 Sep; 47(9):1947-55. PubMed ID: 2593268
    [No Abstract]   [Full Text] [Related]  

  • 45. [Catecholamine responses to sympathetic stimulation in essential hypertension classified according to the WHO classification].
    Hayashi Y
    Nihon Ronen Igakkai Zasshi; 1983 Jul; 20(4):312-20. PubMed ID: 6663817
    [No Abstract]   [Full Text] [Related]  

  • 46. Choice of control groups in the appraisal of sympathetic nervous activity in essential hypertension.
    Jones DH; Hamilton CA; Reid JL
    Clin Sci (Lond); 1979 Oct; 57(4):339-44. PubMed ID: 509873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determination of noradrenaline uptake, spillover to plasma and plasma concentration in patients with essential hypertension.
    Esler M; Jackman G; Leonard P; Bobik A; Skews H; Jennings G; Kelleher D; Korner P
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():311s-313s. PubMed ID: 7449275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Noradrenaline clearance in hypertensive patients with various degrees of renal function.
    Masuyama Y; Nishimura T; Nishio I; Kuchii M
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():213s-215s. PubMed ID: 540434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relation of plasma noradrenaline to blood pressure, age, sex and sodium balance in patients with stable essential hypertension and in normotensive subjects.
    Brecht HM; Schoeppe W
    Clin Sci Mol Med Suppl; 1978 Dec; 4():81s-83s. PubMed ID: 282104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sympathetic hyperreactivity in offspring of essential hypertensive patients.
    Nielsen JR; Gram LF; Fabricius J; Harvald B
    Life Sci; 1984 Jun; 34(26):2551-8. PubMed ID: 6738296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disturbed noradrenergic blood pressure control in normotensive members of hypertensive families.
    Bianchetti MG; Weidmann P; Beretta-Piccoli C; Rupp U; Boehringer K; Link L; Ferrier C
    Br Heart J; 1984 Mar; 51(3):306-11. PubMed ID: 6696808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Total, and organ-specific, noradrenaline plasma kinetics in essential hypertension.
    Esler M; Jennings G; Korner P; Blombery P; Burke F; Willett I; Leonard P
    Clin Exp Hypertens A; 1984; 6(1-2):507-21. PubMed ID: 6697562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Noradrenaline release and sympathetic nervous system activity.
    Esler MD; Hasking GJ; Willett IR; Leonard PW; Jennings GL
    J Hypertens; 1985 Apr; 3(2):117-29. PubMed ID: 2991369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aortic rigidity and plasma catecholamines in essential hypertensive patients.
    Alicandri CL; Agabiti-Rosei E; Fariello R; Beschi M; Boni E; Castellano M; Montini E; Romanelli G; Zaninelli A; Muiesan G
    Clin Exp Hypertens A; 1982; 4(7):1073-83. PubMed ID: 7116658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The 'adrenaline hypothesis' of hypertension revisited: evidence for adrenaline release from the heart of patients with essential hypertension.
    Rumantir MS; Jennings GL; Lambert GW; Kaye DM; Seals DR; Esler MD
    J Hypertens; 2000 Jun; 18(6):717-23. PubMed ID: 10872556
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.
    Brecht HM; Banthien F; Schoeppe W
    Klin Wochenschr; 1976 Nov; 54(22):1095-105. PubMed ID: 1003867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Norepinephrine clearance and pressor effect in normal and hypertensive man.
    Grimm M; Weidmann P; Keusch G; Meier A; Glück Z
    Klin Wochenschr; 1980 Nov; 58(21):1175-81. PubMed ID: 7453102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma noradrenaline correlates with alpha-adrenoreceptor-mediated vasoconstriction and blood pressure in patients with essential hypertension.
    Kiowski W; Van Brummelen P; Bühler FR
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():177s-180s. PubMed ID: 232021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma noradrenaline and adrenaline levels in eclampsia. A preliminary study.
    Moodley J; McFadyen ML; Dilraj A; Rangiah S
    S Afr Med J; 1991 Aug; 80(4):191-2. PubMed ID: 1876955
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adrenergic nervous system and left ventricular mass in primary hypertension.
    Ferrara LA; Mancini M; de Simone G; Pisanti N; Capone D; Fasano ML; Mancini M
    Eur Heart J; 1989 Nov; 10(11):1036-40. PubMed ID: 2591395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.